A. Trifan, “Effectiveness of 8-week Treatment with Glecaprevir/Pibrentasvir in Treatment-naïve or -experienced HCV Patients: Results from an Observational Retrospective Study in Real-life Settings (ODYSSEY)”, JGLD, vol. 33, no. 4, pp. 503-509, Dec. 2024.